Part, Chapter, Paragraph
1 -, 1 | Future developments; (vii) References; and (viii) Acronyms.~ ~
2 I, 2. 11 | 2.11. References~ ~APPLICA (2005): Network
3 I, 3. 4 | 3.4. References~ ~Beets G, Dourleijn E,
4 II, 4. 3 | 4.3. References~ ~Anderson R, Kochanek K,
5 II, 5. 2. 6 | et al, 2007).~ ~Focus Box References (missing references can
6 II, 5. 2. 6 | Box References (missing references can be found in 5.2.7)~Baigent
7 II, 5. 2. 7 | 5.2.7. References~Allender S, Scarborough
8 II, 5. 3. 9 | 5.3.8 References~ ~Berrino F, De Angelis
9 II, 5. 4. 8 | 5.4.8. References~Armesto SG, Lapetra ML,
10 II, 5. 5. 1 | 5.5.1.6. References~ ~Alonso J, Angermeyer MC,
11 II, 5. 5. 2 | 5.5.2.7. References~ ~Alzheimer Europe (2006):
12 II, 5. 5. 3 | 5.5.3.1.7. References~Alexander D, Rigby M, (in
13 II, 5. 5. 3 | 5.5.3.2.6. References~AGREE Collaboration (2003):
14 II, 5. 5. 3 | 5.5.3.3.6. References~ ~Blaxill MF (2004): What’
15 II, 5. 5. 3 | 5.5.3.4.6. References~ ~Anonymous (2003): Living
16 II, 5. 5. 3 | Disabilities~ ~There are number of references in the UN Convention on
17 II, 5. 5. 3 | 5.5.3.5.7. References~ ~Bajenaru O, Pascu I (2004):
18 II, 5. 5. 3 | 5.5.3.6.7. References~Aarsland D, Larsen JP, Tandberg
19 II, 5. 6. 6 | 5.6.6. References~ ~Altman R, Asch E, Bloch
20 II, 5. 7. 7 | 5.7.7. References~American Diabetes Association (
21 II, 5. 8. 7 | 5.8.7. References~ ~ ~American Thoracic Society (
22 II, 5. 9. FB | 5.FB.9. References~ ~Plumb J, Brawer R, Brisbon
23 II, 5. 9. 4 | children compared to their references.~ ~Allergen exposure has
24 II, 5. 9. 7 | 5.9.7. References~ ~Alfvén T (2006): Allergic
25 II, 5. 10. 7 | 5.10.7. References~ ~Asero R, Ballmer-Weber
26 II, 5. 11. 3 | the actual legislation.~ ~References~ ~CRF Azevedo, Characterisation
27 II, 5. 11. 7 | 5.11.7. References~ ~Böhme M, Svensson Å, et
28 II, 5. 12. 7 | 5.12.7. References~ ~Alter MJ, Kruszon-Moran
29 II, 5. 13 | nutrition.~For the quoted references, see Chapter 10.2.1.7.~ ~ ~
30 II, 5. 14. 8 | 5.14.8. References~ ~Bourgeois DM, Baehni PC.
31 II, 5. 15. 6 | 5.15.6. References~ ~ALCIMED (2004): Study
32 II, 6. 2. 0(2)| References to these sources are available
33 II, 7. 7 | 7.7. References~ ~APOLLO – Hospital discharge
34 II, 8. 1. 6 | 8.1.6. References~ ~APPLICA & CESEP & ALPHAMETRICS (
35 II, 8. 2. 1 | and convenience samples. References included in this Chapter
36 II, 8. 2. 1 | 8.2.1.7. References~ ~American Association on
37 II, 8. 2. 2 | 8.2.2.6. References~ ~Donnelly UM, Stewart NM
38 II, 8. 2. 3 | 8.2.3.4. References~ ~Davis AC (1989): The prevalence
39 II, 9 | pesticides and solvents.~ ~References cited in the section on
40 II, 9 | listed in Chapter 9.1.2; references cited in the other paragraphs
41 II, 9 | handicap for the individual.~ ~References cited in this table are
42 II, 9 | and circulatory disease.~ ~References cited in this table are
43 II, 9 | factor (WHO/HEN, 2004).~ ~References cited in this table are
44 II, 9. 1. 1 | 9.1.1.4. References~ ~Ananth CV, Joseph KS,
45 II, 9. 1. 2 | pesticides and solvents.~ ~References cited in the section on
46 II, 9. 1. 2 | listed in Chapter 9.1.2; references cited in the other paragraphs
47 II, 9. 1. 2 | 9.1.2.7. References~ ~Abramsky L, Dolk H and
48 II, 9. 2. 3 | of children, though those references are strong and underline
49 II, 9. 2. 4 | handicap for the individual.~ ~References cited in this table are
50 II, 9. 2. 7 | 9.2.7. References~ ~Alexander D, Rigby M,
51 II, 9. 3. 1 | and circulatory disease.~ ~References cited in this table are
52 II, 9. 3. 1 | 9.3.1.7. References~ ~Arber S, McKinlay J, Adams
53 II, 9. 3. 2 | 9.3.2.7. References~ ~ ~Alexander S, Wildman
54 II, 9. 3. 3 | 9.3.3.6. References~ ~Amaro F, Frazão C, Pereire
55 II, 9. 4. 4 | factor (WHO/HEN, 2004).~ ~References cited in this table are
56 II, 9. 4. 7 | 9.4.7. References~ ~Bhalla et al, (2004):
57 II, 9. 5. 6 | 9.5.6. References~ ~Age Concern (2007a). Available
58 III, 10. 1. 3 | 10.1.3. References~Ambler C, Eliakim A, Brasel
59 III, 10. 2. 1 | 10.2.1.1.7. References~ ~Action on smoking and
60 III, 10. 2. 1 | 10.2.1.2.5. References~ ~Anderson P, Baumberg B (
61 III, 10. 2. 1 | 10.2.1.3.6. References~ ~Bargagli et al. (2002) ‘
62 III, 10. 2. 1 | 10.2.1.5.6. References~ ~Arnadottir IB, Ketley
63 III, 10. 2. 1 | 10.2.1.6.6. References~ ~Bauman A and Miller Y (
64 III, 10. 2. 1 | specific reports listed under references.~ ~b) Food consumption and
65 III, 10. 2. 1 | 10.2.1.7.8. References~ ~Overweight and obesity:~ ~
66 III, 10. 2. 2 | For more details and references, see Chapter 5.2.~ ~ ~
67 III, 10. 2. 3 | For more details and references, see Chapter 5.2.~ ~ ~
68 III, 10. 2. 4 | 10.2.4.6. References~ ~Brand A (2002): Prädiktive
69 III, 10. 2. 5 | 10.2.5.6. References~Allen JP, Porter M, McFarland
70 III, 10. 3. 1 | 10.3.1.6. References~ ~Babisch W (2006): Transportation
71 III, 10. 3. 2 | 10.3.2.6. References~ ~Asia-Europe Foundation (
72 III, 10. 3. 3 | 10.3.3.6. References~ ~See Chapter 6.~ ~
73 III, 10. 3. 4 | 10.3.4.6. References~ ~Solomon, 2007~ICC, 2007a~
74 III, 10. 4. 1 | 10.4.1.6. References~ ~AirBase – the European
75 III, 10. 4. 2 | Member Countries, the OIE References Laboratories and Collaborating
76 III, 10. 4. 2 | 10.4.2.6. References~ ~European Commission (2002):
77 III, 10. 4. 3 | 10.4.3.6. References~ ~European Commission (1976):
78 III, 10. 4. 5 | social activities depend.~ ~References~European Commission (2000):
79 III, 10. 4. 5 | for proper treatment.~ ~References~ ~European Commission (1994):
80 III, 10. 5. 1 | 10.5.1.8. References~Bagaeen SG (2006): Redeveloping
81 III, 10. 5. 2 | 10.5.2.6. References~ ~British Medical Association (
82 III, 10. 5. 3 | 10.5.3.6. References~ ~Aldana StG, Financial
83 III, 10. 6. 1 | 10.6.1.6. References~ ~Austin DM, et al (2002):
84 III, 10. 6. 2 | documents listed in the References Section.~ ~ ~ ~
85 III, 10. 6. 2 | 10.6.2.6. References~ ~Berkman, L. & Glass, T. (
86 III, 10. 6. 3 | 10.6.3.5. References~ ~EUICS (2005): The Burden
87 IV, 11. 6. 5 | 11.7. References~ ~Altman S, Blendon R Eds. (
88 IV, 12. 10 | Stammzellgesetz). Further references to bioethical subjects see
89 IV, 13. 9 | 13.9. References~ ~Andlin-Sobocki P, Jönsson
